Physicians’ and patients’ perception of biosimilars and factors affecting biosimilar prescribing in selected Asian countries: a survey study
Programs focused on cost/coverage support, patient support, and biosimilar awareness could improve acceptance of biosimilars for chronic immune-mediated inflammatory diseases in Asian countries, thereby increasing patient access to essential biologic therapies.
Authors
- Anupam Das (ORCID: https://orcid.org/0000-0003-0841-9597)
- James Wee (ORCID: https://orcid.org/0000-0001-7433-8176)
- Supat Thongpooswan (ORCID: https://orcid.org/0000-0003-4924-456X)
- Mark Latymer
- Pravin Patil
- Lyndon Llamado
Institutions
- Pfizer (United Kingdom) (GB)
- KPC Medical College and Hospital (IN)
- Bumrungrad International Hospital (TH)
- Hyderabad Rheumatology Center (IN)
- Taguig City University (PH)
- University of Santo Tomas (PH)
Publication Details
- Journal
- Expert Opinion on Biological Therapy
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1080/14712598.2024.2400523
- Citations
- 5
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.20
Funders
- Pfizer